2022
Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania
Zhu J, Lyatuu G, Sudfeld CR, Kiravu A, Sando D, Machumi L, Minde J, Chisonjela F, Cohen T, Menzies NA. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania. The Lancet Global Health 2022, 10: e1646-e1654. PMID: 36240830, PMCID: PMC9553191, DOI: 10.1016/s2214-109x(22)00372-2.Peer-Reviewed Original ResearchConceptsIsoniazid preventive therapyCD4 cell countAntiretroviral therapyCell countART cohortAverage CD4 cell countHigher CD4 cell countsLarge HIV treatment programHealth impactsTuberculosis preventive treatmentHIV treatment programsLifetime costsIncremental lifetime costLifetime health benefitsCourse of infectionGreater health gainsLong-term healthART initiationTreat guidelinesHIV cohortPreventive therapyTuberculosis riskUS National InstitutesHIV programsSubgroup analysisExcess tuberculosis cases and deaths following an economic recession in Brazil: an analysis of nationally representative disease registry data
Li Y, de Macedo Couto R, Pelissari DM, Costa Alves L, Bartholomay P, Maciel EL, Sanchez M, Castro MC, Cohen T, Menzies NA. Excess tuberculosis cases and deaths following an economic recession in Brazil: an analysis of nationally representative disease registry data. The Lancet Global Health 2022, 10: e1463-e1472. PMID: 36049488, PMCID: PMC9472578, DOI: 10.1016/s2214-109x(22)00320-5.Peer-Reviewed Original ResearchConceptsNational Notifiable Diseases Information SystemTuberculosis casesTuberculosis deathsExcess casesTuberculosis case ratesTuberculosis transmissionCase ratesNotifiable Diseases Information SystemTuberculosis case notificationDisease registry dataMortality Information SystemMixed effects regression modelsSupplementary Materials sectionFraction of casesTuberculosis controlUS National InstitutesTuberculosis incidenceCase notificationRegistry dataExcess deathsAge groupsDeathPossible explanatory factorsNational InstituteYoung men
2021
Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis
Cords O, Martinez L, Warren JL, O’Marr J, Walter KS, Cohen T, Zheng J, Ko AI, Croda J, Andrews JR. Incidence and prevalence of tuberculosis in incarcerated populations: a systematic review and meta-analysis. The Lancet Public Health 2021, 6: e300-e308. PMID: 33765455, PMCID: PMC8168455, DOI: 10.1016/s2468-2667(21)00025-6.Peer-Reviewed Original ResearchConceptsPrevalence of tuberculosisIncidence of tuberculosisM tuberculosis infectionIncidence rate ratiosTuberculosis infectionGeneral populationSystematic reviewSouth-East Asia RegionIncarcerated populationsPopulation-level incidenceMycobacterium tuberculosis infectionRate ratioTuberculosis Control ProgrammeLILACS electronic databasesWHO Eastern Mediterranean RegionWHO South-East Asia RegionWeb of KnowledgeCohort studyUS National InstitutesSubgroup analysisPooled estimatesHigh riskElectronic databasesPreventive interventionsTuberculosis
2018
Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis
Yang C, Lu L, Warren JL, Wu J, Jiang Q, Zuo T, Gan M, Liu M, Liu Q, DeRiemer K, Hong J, Shen X, Colijn C, Guo X, Gao Q, Cohen T. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. The Lancet Infectious Diseases 2018, 18: 788-795. PMID: 29681517, PMCID: PMC6035060, DOI: 10.1016/s1473-3099(18)30218-4.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overChinaDisease Transmission, InfectiousFemaleGenotypeHumansMaleMiddle AgedMinisatellite RepeatsMolecular EpidemiologyMycobacterium tuberculosisPolymorphism, Single NucleotideRural PopulationSpatial AnalysisTransients and MigrantsTuberculosisUrban PopulationWhole Genome SequencingConceptsM tuberculosisEpidemiological dataSingle nucleotide polymorphismsCulture-positive Mycobacterium tuberculosis isolatesCulture-positive tuberculosisPopulation-based studyMycobacterium tuberculosis isolatesTransmission dynamicsTime of infectionDynamics of tuberculosisTuberculosis controlUS National InstitutesTuberculosis isolatesMore effective interventionsProximity of residenceRecent transmissionPatient's homeTuberculosisLocal transmission dynamicsEffective interventionsLocal transmissionLocal incidenceNational InstituteVNTR patternsWhole-genome sequencing
2014
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. The Lancet 2014, 383: 1572-1579. PMID: 24671080, PMCID: PMC4094366, DOI: 10.1016/s0140-6736(14)60195-1.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisMultidrug-resistant tuberculosis diseaseTreatment-naive adultsMultidrug-resistant diseaseTuberculosis diseaseTuberculosis incidenceGlobal incidenceSystematic reviewCases of tuberculosisHarvard Medical SchoolGlobal tuberculosis incidenceGlobal annual incidenceTuberculosis riskAnnual incidencePatient groupUS National InstitutesWomen's HospitalInclusion criteriaInternal medicineNew diagnostic instrumentDisease riskTuberculosisIncidenceDiseaseHealth equity